Home / Find a Study

Depression (DENOVO)

#

Depression (DENOVO)

  • Compensation to be determined
  • 13 visits (enrollment open)
#

Between 18 - 65 Years

#
Male or Female
#
Smoker & Non-Smoker
# Share Refer a Friend

Description

A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients with Treatment Resistant Depression(TRD). Approximately 180 patients with TRD who meet all eligibility criteria will be randomized in a 1:1:1 ratio to receive either Liafensine 1 mg QD, Liafensine 2 mg QD, or placebo QD for 6 weeks.

Is this not what you are looking for?
Check out our other studies.

Find a Study

Related Studies

#

Depression (DENOVO)

  • Compensation to be determined
  • 8 office visits (including one post-study) and 1 follow-up call post-study
#
Between 18 - 65 Years

#
Male or Female
#
Smoker & Non-Smoker
#

Chronic Idiopathic Urticaria

  • Compensation to be determined
  • 13 clinic visits including 3 safety follow-up visits
#
Between 18 - 75 Years

#
Male or Female
#
Smoker & Non-Smoker
#

COPD

  • Compensation to be determined
  • 12 clinic visits
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2023 Access Research Institute. All Rights Reserved
✖